News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
891,385 Results
Type
Article (89317)
Company Profile (560)
Press Release (801479)
Multimedia
Podcasts (266)
Webinars (41)
Section
Business (267285)
Career Advice (4173)
Deals (40085)
Drug Delivery (211)
Drug Development (91960)
Employer Resources (210)
FDA (18686)
Job Trends (17530)
News (399278)
Policy (40036)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (3087)
Academic (2)
Accelerated approval (68)
ADA (51)
Adcomms (44)
Allergies (221)
Alliances (56993)
ALS (261)
Alzheimer's disease (2087)
Antibody-drug conjugate (ADC) (665)
Approvals (19158)
Artificial intelligence (1029)
ASCO (345)
Autoimmune disease (436)
Automation (74)
Bankruptcy (412)
Belgium (7)
Best Places to Work (12635)
BIO (81)
Biologics (15)
BIOSECURE Act (23)
Biosimilars (281)
BioSpace Insights (253)
Biotechnology (340)
Bispecific (1)
Bladder cancer (229)
Brain cancer (95)
Breast cancer (912)
Cancer (7300)
Cardiovascular disease (631)
Career advice (3620)
Career pathing (61)
CAR-T (422)
CDC (77)
CDMO (176)
Celiac Disease (4)
Cell therapy (1169)
Cervical cancer (61)
Clinical research (80100)
Collaboration (2658)
Commercialization (13)
Company closure (10)
Compensation (1776)
Complete response letters (123)
COVID-19 (3061)
CRISPR (139)
C-suite (1568)
Cystic fibrosis (178)
Data (9707)
Decentralized trials (3)
Denatured (104)
Depression (218)
Dermatology (130)
Diabetes (768)
Diagnostics (7805)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (518)
Drug pricing (251)
Drug shortages (39)
Duchenne muscular dystrophy (363)
Earnings (103694)
Editorial (83)
Employer branding (26)
Employer resources (180)
Events (140099)
Executive appointments (1321)
Eye disease (1)
FDA (23359)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (39)
Funding (2191)
Gene editing (299)
Generative AI (104)
Gene therapy (922)
GLP-1 (1339)
Government (5603)
Grass and pollen (8)
Guidances (435)
Healthcare (21388)
Hematology (198)
HIV (116)
Huntington's disease (77)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (134)
Immunology and inflammation (398)
Immuno-oncology (140)
Indications (247)
Infectious disease (3492)
Inflammatory bowel disease (252)
Inflation Reduction Act (17)
Influenza (160)
Intellectual property (362)
Interviews (826)
IPO (18043)
IRA (61)
Job creations (5211)
Job search strategy (2879)
JPM (73)
Kidney cancer (28)
Labor market (137)
Layoffs (713)
Leadership (60)
Legal (10176)
Licensing (29)
Liver cancer (115)
Longevity (45)
Lung cancer (997)
Lymphoma (521)
Machine learning (75)
Management (70)
Manufacturing (1473)
Marketing (14)
MASH (240)
Medical affairs (3)
Medical device (15412)
Medtech (15678)
Mergers & acquisitions (23506)
Metabolic disorders (1980)
mRNA (307)
Multiple sclerosis (226)
Multispecific (1)
NASH (24)
Netherlands (5)
Neurodegenerative disease (582)
Neuropsychiatric disorders (146)
Neuroscience (4074)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5162)
Now hiring (93)
Obesity (935)
Opinion (397)
Ovarian cancer (264)
Pain (320)
Pancreatic cancer (405)
Parkinson's disease (456)
Partnered (48)
Patents (758)
Patient advocacy (1)
Patient recruitment (952)
Patient selection (3)
Peanut (74)
People (68703)
Peptides (7)
Pharmaceutical (83)
Pharmacy benefit managers (40)
Phase 1 (24723)
Phase 2 (34756)
Phase 3 (26196)
Pipeline (12284)
Policy (416)
Postmarket research (3561)
Preclinical (11062)
Press Release (72)
Prostate cancer (379)
Psychedelics (92)
Radiopharmaceuticals (413)
Rare diseases (1476)
Real estate (7473)
Recruiting (83)
Regenerative medicine (1)
Regulatory (31314)
Reports (92)
Research institute (2803)
Resumes & cover letters (656)
Rett syndrome (52)
RNA editing (33)
RSV (102)
Schizophrenia (210)
Series A (374)
Series B (269)
Service/supplier (16)
Sickle cell disease (138)
Special edition (35)
Spinal muscular atrophy (197)
Sponsored (58)
Startups (4388)
State (2)
Stomach cancer (22)
Supply chain (159)
Tariffs (105)
The Weekly (159)
Vaccines (1389)
Venture capital (161)
Weight loss (631)
Wet AMD (1)
Women's health (167)
Worklife (27)
Date
Today (130)
Last 7 days (634)
Last 30 days (2617)
Last 365 days (33549)
2026 (24012)
2025 (33213)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1302)
Alabama (112)
Alaska (7)
Arizona (455)
Arkansas (16)
Asia (52810)
Australia (9296)
California (15920)
Canada (4441)
China (1846)
Colorado (680)
Connecticut (712)
Delaware (493)
Europe (121821)
Florida (2422)
Georgia (522)
Hawaii (5)
Idaho (70)
Illinois (1382)
India (132)
Indiana (723)
Iowa (31)
Japan (703)
Kansas (152)
Kentucky (65)
Louisiana (68)
Maine (95)
Maryland (1910)
Massachusetts (11586)
Michigan (456)
Minnesota (879)
Mississippi (7)
Missouri (180)
Montana (37)
Nebraska (31)
Nevada (177)
New Hampshire (92)
New Jersey (4186)
New Mexico (38)
New York (4169)
North Carolina (2099)
North Dakota (12)
Northern California (8040)
Ohio (511)
Oklahoma (31)
Oregon (49)
Pennsylvania (3060)
Puerto Rico (34)
Rhode Island (57)
South America (1672)
South Carolina (96)
South Dakota (2)
Southern California (6313)
Tennessee (267)
Texas (2610)
United States (56663)
Utah (482)
Vermont (2)
Virginia (403)
Washington D.C. (88)
Washington State (1289)
West Virginia (4)
Wisconsin (179)
Wyoming (4)
There are 891,385 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
When vision fades: Rethinking wet AMD and the durability gap
In this episode of Denatured, you’ll hear Philip Jacob Rosenfeld, professor of Ophthalmology at the University of Miami Health System and Bascom Palmer Eye Institute, and Wesley Jackson, chief science officer at Valitor. We talk about the eye condition call wet age-related macular degeneration (AMD), the limits of anti‑VEGF therapy and the push for true durability to change a patient’s life.
September 17, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes
September 17, 2026
·
15 min read
Press Releases
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
September 17, 2026
·
8 min read
Press Releases
Merz Therapeutics Receives EU/EEA Approval for XEOMIN® for the Treatment of Pediatric Spasticity Associated With Pes Equinus
September 17, 2026
·
4 min read
Press Releases
WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development
September 17, 2026
·
4 min read
Press Releases
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
September 17, 2026
·
3 min read
Press Releases
Innate Pharma Reports First Half 2026 Business Update and Financial Results
September 17, 2026
·
20 min read
Press Releases
Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study
September 17, 2026
·
15 min read
Press Releases
New Meta-Analysis Strengthens Clinical Evidence for DiviTum TKa in Metastatic Breast Cancer
September 17, 2026
·
2 min read
Press Releases
Akeso’s EGFR/TROP2 Bispecific ADC AK158D1 Granted NMPA Phase I Clearance for Advanced Solid Tumors, Marking Its Fourth Clinical-Stage ADC Candidate
September 17, 2026
·
6 min read
1 of 89,139
Next
